Skip to main content
. 2022 Sep 6;41(12):2895–2902. doi: 10.1016/j.clnu.2022.08.023

Table 1.

Main characteristics and outcomes and comparison depending on vital status at the end of ICU stay.

Variables N(%) or median (IQR) ICU survivors
N = 69
ICU non-survivors
N = 30
p
Age (years) 71 [60.6; 76.2] 68.9 [58.7; 75.9] 73.9 [67.6; 78] 0.02
Sex (Male) 64 (64.6) 45 (65.2) 19 (63.3) 0.86
BMI (kg/m2) 29.4 [25.5; 32.7] 29.7 [25.8; 32.9] 29.2 [25.5; 32.4] 0.92
BMI >30 kg/m2 45 (45.5) 31 (44.9) 14 (46.7) 0.87
Comorbidities
Cardio-vascular 15 (15.2) 6 (8.7) 9 (30) <0.01
Respiratory 5 (5.1) 3 (4.3) 2 (6.7) 0.63
Renal 6 (6.1) 2 (2.9) 4 (13.3) 0.05
Liver 1 (1) 0 (0) 1 (3.3) 0.13
Immunocompromised host 15 (15.2) 10 (14.5) 5 (16.7) 0.78
Diabetes 15 (15.2) 12 (17.4) 3 (10) 0.35
Time from first symptoms to ICU admission 9 [7; 11] 9 [8; 11] 7.5 [5; 9] <0 0.01
On admission (Day 1 or Day 2)
Steroids 86 (86.9) 60 (87) 26 (86.7) 0.97
Diuretics 84 (84.8) 58 (84.1) 26 (86.7) 0.74
SAPS II 32 [22; 41] 32 [22; 41] 33.5 [22; 44] 0.55
SOFA score 4 [3; 6] 4 [3; 5] 5 [4; 6] 0.03
PaO2/FiO2 86.9 [68; 138.8] 92.7 [76.3; 140] 86 [61.1; 109.2] 0.24
Invasive mechanical ventilation 7 (7.1) 6 (8.7) 1 (3.3) 0.34
High Flow Nasal Canula 58 (58.6) 35 (50.7) 23 (76.7) 0.02
Vasopressors 7 (7.1) 5 (7.2) 2 (6.7) 0.92
Treatments during ICU stay
Invasive mechanical ventilation 31 (31.3) 11 (15.9) 20 (66.7) <0.01
Renal replacement therapy 8 (8.1) 2 (2.9) 6 (20) <0.01
Vasopressors 28 (28.3) 10 (14.5) 18 (60) <0.01
Diuretics 96 (97) 66 (95.7) 30 (100) 0.25
ICU LOS 8 [5; 14] 7 [5; 10] 15 [7; 24] <0.01
Hospital LOS 17 [11; 28] 17 [11.5; 29] 15.5 [9; 24] 0.30
ICU Death 30 (30.3)

ICU: Intensive Care Unit; IQR: Interquartile; P: pvalue; BMI: Body Mass Index; SAPS: Simplified Acute Physiology Score; SOFA: Sequential Organ Failure Assessment; LOS: Length of stay.